GlaxoSmithKline says it is investigating bribery claims in Jordan and Lebanon

Allegations say GSK sales representatives bribed doctors by issuing free samples that they were then allowed to sell on

GlaxoSmithKline, the UK’s largest drug firm, is investigating claims that its staff in Jordan and Lebanon have bribed doctors. The inquiry comes after separate allegations of unscrupulous behaviour by staff in China, Iraq and Poland, with the last two of those cases both emerging earlier this month.

"GSK can confirm we are investigating allegations regarding the activity of a small number of individuals in our operations in Jordan and Lebanon," the company said in statement. "We started investigating using internal and external teams as soon as we became aware of these claims. These investigations have not yet concluded."

Continue reading…
Pharmaceuticals industry | The Guardian

Pharmaceutical Stocks


© 2017 Drugs News All rights reserved.       Privacy Policy       Contact Us